CLF MEDICAL TECHNOLOGY ACCELERATION PROGRAM INC has a total of 28 patent applications. Its first patent ever was published in 1999. It filed its patents most often in WIPO (World Intellectual Property Organization), Australia and Canada. Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are SURVAC APS, CHUGH SUMANT S and APITOPE TECHNOLOGY BRISTOL LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 9 | |
#2 | Australia | 7 | |
#3 | Canada | 4 | |
#4 | EPO (European Patent Office) | 4 | |
#5 | United States | 3 | |
#6 | China | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Measurement | |
#4 | Environmental technology | |
#5 | Organic fine chemistry | |
#6 | Agriculture | |
#7 | Micro-structure and nano-technology |
# | Name | Total Patents |
---|---|---|
#1 | Davis Paul J | 9 |
#2 | Bennett James A | 6 |
#3 | Karliner Joel S | 6 |
#4 | Mesfin Fassil B | 6 |
#5 | Jacobson Herbert I | 6 |
#6 | Andersen Thomas T | 6 |
#7 | Gopal Damodara | 4 |
#8 | Kempf Vern J | 4 |
#9 | Stalzer Walter | 4 |
#10 | Mousa Shaker A | 3 |
Publication | Filing date | Title |
---|---|---|
WO2008140507A2 | Nanoparticle and polymer formulations for thyroid hormone analogs, antagonists, and formulations and uses thereof | |
WO2007130509A2 | Pyrroloquinoline quinones and use thereof | |
CN101193888A | Synthesis of pyrroloquinoline quinone (PQQ) | |
EP1866307A1 | Synthesis of pyrroloquinoline quinone (pqq) | |
WO2005107871A2 | Pyrroloquinoline quinone drugs for treatment of cardiac injury | |
CA2456910A1 | Drugs for treatment of cerebral injury and methods of use thereof | |
AU2002320460A1 | Calcineurin modulators | |
US6818741B2 | Alpha-fetoprotein peptides and uses therof | |
US6777388B1 | Leptin-related peptides |